Format
Sort by
Items per page

Send to

Choose Destination

Links from NLM Catalog

Items: 1 to 20 of 232

1.

Multispectral fluorescence guided surgery; a feasibility study in a phantom using a clinical-grade laparoscopic camera system.

van Willigen DM, van den Berg NS, Buckle T, KleinJan GH, Hardwick JC, van der Poel HG, van Leeuwen FW.

Am J Nucl Med Mol Imaging. 2017 Jul 15;7(3):138-147. eCollection 2017.

2.

Role of conventional magnetic resonance imaging in the screening of epilepsy with structural abnormalities: a pictorial essay.

Zhao X, Zhou Z, Zhu W, Xiang H.

Am J Nucl Med Mol Imaging. 2017 Jul 15;7(3):126-137. eCollection 2017. Review.

3.

Fully automated GMP production of [68Ga]Ga-DO3A-VS-Cys40-Exendin-4 for clinical use.

Velikyan I, Rosenstrom U, Eriksson O.

Am J Nucl Med Mol Imaging. 2017 Jul 15;7(3):111-125. eCollection 2017.

4.

Imaging features of Paget's disease on 11C choline PET/CT.

Leitch CE, Goenka AH, Howe BM, Broski SM.

Am J Nucl Med Mol Imaging. 2017 Jul 15;7(3):105-110. eCollection 2017.

5.

Value of 99mTc-MDP SPECT/CT and 18F-FDG PET/CT scanning in the evaluation of malignantly transformed fibrous dysplasia.

Wei WJ, Sun ZK, Shen CT, Zhang XY, Tang J, Song HJ, Qiu ZL, Luo QY.

Am J Nucl Med Mol Imaging. 2017 Jul 15;7(3):92-104. eCollection 2017.

6.

Correlation between two methods of florbetapir PET quantitative analysis.

Breault C, Piper J, Joshi AD, Pirozzi SD, Nelson AS, Lu M, Pontecorvo MJ, Mintun MA, Devous MD.

Am J Nucl Med Mol Imaging. 2017 Jul 15;7(3):84-91. eCollection 2017.

7.

Efficacy of peptide receptor radionuclide therapy with 177Lu-octreotate in metastatic pulmonary neuroendocrine tumors: a dual-centre analysis.

Sabet A, Haug AR, Eiden C, Auernhammer CJ, Simon B, Bartenstein P, Biersack HJ, Ezziddin S.

Am J Nucl Med Mol Imaging. 2017 Apr 15;7(2):74-83. eCollection 2017.

8.

Radionuclide bone scan SPECT-CT: lowering the dose of CT significantly reduces radiation dose without impacting CT image quality.

Gupta SK, Trethewey S, Brooker B, Rutherford N, Diffey J, Viswanathan S, Attia J.

Am J Nucl Med Mol Imaging. 2017 Apr 15;7(2):63-73. eCollection 2017.

9.

A phase one, single-dose, open-label, clinical safety and PET/MR imaging study of 68Ga-DOTATOC in healthy volunteers.

Esfahani SA, Salcedo S, Heidari P, Catalano OA, Pauplis R, Hesterman J, Kronauge JF, Mahmood U.

Am J Nucl Med Mol Imaging. 2017 Apr 15;7(2):53-62. eCollection 2017.

10.

Synthesis and evaluation of [64Cu]PSMA-617 targeted for prostate-specific membrane antigen in prostate cancer.

Cui C, Hanyu M, Hatori A, Zhang Y, Xie L, Ohya T, Fukada M, Suzuki H, Nagatsu K, Jiang C, Luo R, Shao G, Zhang M, Wang F.

Am J Nucl Med Mol Imaging. 2017 Apr 15;7(2):40-52. eCollection 2017.

11.

64CuCl2 PET/CT imaging of mouse muscular injury induced by electroporation.

Xie F, Cai H, Peng F.

Am J Nucl Med Mol Imaging. 2017 Jan 15;7(1):33-39. eCollection 2017.

12.

Automated quantitation of cold-inducible human brown adipose tissue with FDG PET/CT with application to fibromyalgia.

Pardo JV, Lee JT, Larson RC, Thuras P, Larson AA.

Am J Nucl Med Mol Imaging. 2017 Jan 15;7(1):24-32. eCollection 2017.

13.

Diagnostic performance of an automated analysis software for the diagnosis of Alzheimer's dementia with 18F FDG PET.

Partovi S, Yuh R, Pirozzi S, Lu Z, Couturier S, Grosse U, Schluchter MD, Nelson A, Jones R, O'Donnell JK, Faulhaber P.

Am J Nucl Med Mol Imaging. 2017 Jan 15;7(1):12-23. eCollection 2017.

14.

Performance characteristics and relationship of PSA value/kinetics on carbon-11 acetate PET/CT imaging in biochemical relapse of prostate cancer.

Almeida FD, Yen CK, Scholz MC, Lam RY, Turner J, Bans LL, Lipson R.

Am J Nucl Med Mol Imaging. 2017 Jan 15;7(1):1-11. eCollection 2017.

15.

Precision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis.

Ghasemi M, Nabipour I, Omrani A, Alipour Z, Assadi M.

Am J Nucl Med Mol Imaging. 2016 Nov 30;6(6):310-327. eCollection 2016.

16.

Absorbed radiation dosimetry of the D3-specific PET radioligand [18F]FluorTriopride estimated using rodent and nonhuman primate.

Laforest R, Karimi M, Moerlein SM, Xu J, Flores HP, Bognar C, Li A, Mach RH, Perlmutter JS, Tu Z.

Am J Nucl Med Mol Imaging. 2016 Nov 30;6(6):301-309. eCollection 2016.

17.

Utility of 11C-methionine and 11C-donepezil for imaging of Staphylococcus aureus induced osteomyelitis in a juvenile porcine model: comparison to autologous 111In-labelled leukocytes, 99m Tc-DPD, and 18F-FDG.

Afzelius P, Alstrup AK, Schønheyder HC, Borghammer P, Jensen SB, Bender D, Nielsen OL.

Am J Nucl Med Mol Imaging. 2016 Nov 30;6(6):286-300. eCollection 2016.

18.

Prediction of positron emission tomography/computed tomography (PET/CT) positivity in patients with high-risk primary melanoma.

Danielsen M, Kjaer A, Wu M, Martineau L, Nosrati M, Leong SP, Sagebiel RW, Iii JR, Kashani-Sabet M.

Am J Nucl Med Mol Imaging. 2016 Sep 22;6(5):277-285. eCollection 2016.

19.

Validation of true low-dose 18F-FDG PET of the brain.

Fällmar D, Lilja J, Kilander L, Danfors T, Lubberink M, Larsson EM, Sörensen J.

Am J Nucl Med Mol Imaging. 2016 Sep 22;6(5):269-276. eCollection 2016.

20.

SUV measurement of normal vertebrae using SPECT/CT with Tc-99m methylene diphosphonate.

Kaneta T, Ogawa M, Daisaki H, Nawata S, Yoshida K, Inoue T.

Am J Nucl Med Mol Imaging. 2016 Sep 22;6(5):262-268. eCollection 2016.

Supplemental Content

Support Center